Shares of Vylor (NYSE:VYLR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eleven analysts that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $81.38.
Several analysts have commented on the stock. Royal Bank Of Canada started coverage on shares of Vylor in a report on Friday, October 2nd. They issued an “outperform” rating and a $85.00 price objective on the stock. KeyCorp assumed coverage on shares of Vylor in a report on Wednesday. They set a “sector weight” rating and a $78.00 target price for the company. Zacks Research raised shares of Vylor to a “hold” rating in a report on Monday. Morgan Stanley began coverage on shares of Vylor in a report on Friday, October 2nd. They issued an “overweight” rating and a $85.00 price target on the stock. Finally, Bank of America started coverage on shares of Vylor in a report on Monday. They issued a “buy” rating and a $78.00 price target on the stock.
Check Out Our Latest Stock Report on VYLR
Vylor Trading Up 0.1%
Vylor Company Profile
Vylor Inc is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc is based in JOHNSTON, Iowa.
Featured Stories
- Five stocks we like better than Vylor
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Vylor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vylor and related companies with MarketBeat.com's FREE daily email newsletter.
